Livzon Pharmaceutical Group Inc
01513
Company Profile
Business description
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. It is a pharmaceutical group covering pharmaceutical R&D, production and commercialization. The company's products include chemical drugs, biological drugs, and traditional Chinese medicine. It distributes its products within domestic markets and to overseas markets. The company operates in a single operating segment in the PRC, i.e. the manufacture of pharmaceuticals.
Contact
38 Chuangye North Road
Headquarters Building, Jinwan District
Guangdong Province
Zhuhai519090
CHNT: +86 7568135888
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
8,878
Stocks News & Analysis
stocks
ASX gold miner under pressure to sell by activist investor
Activist investor presses gold miner on selling to larger players.
stocks
Ask the Analyst: Will Amcor lose its dividend aristocrat status?
When consistency becomes constraint.
stocks
Chart of the Week: We see opportunity in this beaten down industrial player
The market sees risks and are discounting the shares excessively.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,017.20 | 3.10 | -0.03% |
| CAC 40 | 8,150.42 | 58.67 | -0.71% |
| DAX 40 | 24,795.94 | 328.23 | -1.31% |
| Dow JONES (US) | 50,687.07 | 620.72 | -1.21% |
| FTSE 100 | 10,332.30 | 41.21 | -0.40% |
| HKSE | 25,633.21 | 405.11 | -1.56% |
| NASDAQ | 26,853.98 | 239.92 | -0.89% |
| Nikkei 225 | 68,402.13 | 1,667.89 | 2.50% |
| NZX 50 Index | 13,093.70 | 21.38 | -0.16% |
| S&P 500 | 7,553.68 | 56.10 | -0.74% |
| S&P/ASX 200 | 8,785.70 | 5.90 | 0.07% |
| SSE Composite Index | 4,083.97 | 8.87 | 0.22% |